PCR was used to clone isolates of the human immunodeficiency virus type 1 (HIV-1) nef gene directly from peripheral blood leukocytes of HIIV-1-infected individuals. A transient expression system with human CEM T ceils was used to assess the effect of nefon CD4 antigen expression on the ceHl surface. We show that CD4 down-regulation is a frequent property of primary HIV-1 nefafleles. Mutations in conserved amino acid motifs of Nef disrupted CD4 down-regulation. Our observations strongly suggest that CD4 down-regulation reflects a conserved function of nef, which is selected in vivo in human HIV-1 infection. Methodology described here provides quantitative assays to establish whether alterations in nef correlate with the dynamics of disease progression in human AIDS.
nefgenes of human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2) and simian immunodeficiency virus encode related small cytoplasmic proteins (1, 2) . Data from in vivo experiments in rhesus monkeys indicate that nefis an important pathogenic determinant of these viruses and that nefis essential for high viral load and disease induction in this primate model for human AIDS (3) .
In contrast to the data from in vivo studies, nef is not required for viral replication in primary T cells nor established T-cell lines under the commonly used in vitro conditions (3) (4) (5) , and nef open reading frames (ORFs) from viral isolates that have been propagated in vitro frequently encode prematurely terminated and, hence, most likely nonfunctional Nef proteins (6, 7) . So far no consistent function has been ascribed to nef through the in vitro studies. The initial reports of a negative effect of nefon viral replication (4, 5, 8) and expression (9, 10) were either not confirmed (11, 12) or contradicted (13) by more recent studies. A block to interleukin 2 gene induction was observed in stable cell lines expressing some, but not other, HIV-1 nefalleles (14) . Also, it was reported that nef from the HIV-1 SF2 isolate downmodulates CD4 antigen on the cell surface (15) , but these observations were not confirmed by other studies (16, 17) . We have reported previously that Nefprotein from the HIV-1 NL43 isolate, but not from the HIV-1 HxB3 isolate, downregulated expression of CD4 antigen in human and murine T cells (18) . HIV-1 NL43 Nef had a dramatic effect on development and activation of CD4+ T cells when expressed in transgenic mice, and this correlated with CD4 downregulation on thymic T cells (18) .
The apparently contrasting results from in vitro experiments frequently reflect genetic variation among commonly studied nef alleles (13, 14, 18) , and this variation may result from the absence of selection for nef function upon in vitro propagation of cloned viruses. Therefore, in an attempt to circumvent limitations resulting from lack of genetic selection for nefunder the in vitro conditions, we isolated a large number of HIV-1 nef alleles directly from two patients
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infected with HIV-1. In this report we present results of the analysis of CD4 down-regulation by these primary HIV-1 nef alleles. (18) .
MATERIALS AND METHODS
Analysis of Primary HIV-1 nef Isolates. The nucleotide sequence ofNA and NB clones was determined, as described (20) . Oligonucleotide-directed mutagenesis was done with the NA7 nef, subcloned into the pBS vector (Stratagene), as described (21) . All mutations were verified by DNA sequence analysis. Electroporation, flow cytometry analysis of CEM E5 cells (22) , and immunoblot analysis of Nef expression were done as described (18) . (18) was used to assess the effect of primary nef alleles on CD4 antigen expression on the cell surface. As illustrated in Fig. 2A , transfection with the CD3-LacZ reporter construct, but not with a control CD3 TEX plasmid, resulted in a high level of ,3galactosidase activity in a large fraction of electroporated cells ((-galactosidase-positive cells; compare I and 2), and f3-galactosidase expression had no effect on CD4 expression on the surface of 3-galactosidase-positive cells (compare the right and left upper quadrants in 2). As shown before (18), transfection with the HIV-1 NL43 nef, but not with HxB3 nef, caused an =50-fold decrease in CD4 staining (4 and 5, respectively) .
RESULTS

Cloning of Primary
Results of the analysis of 6 of the 14 CD3 NA clones tested are shown in Fig. 2A, 6 -10, and a compilation of analyses done with nef isolates from the SKi and SK4 patients is shown in Fig. 2B . Expression of Nef from all clones derived from SKi effected a decrease in CD4 antigen expression on the surface of CEM T cells, although to different extents. Interestingly, nefalleles from several of these clones, including NA3, -7, -10, -13, -14, -18, -11, and -15, were more potent in CD4 down-regulation than was NL43 nef. The NA1, -5, -6, -8, and NB1 alleles were as potent as the NL43 Nef. In contrast, the NA4, NA17, NB5, and NB9 alleles were exceptional in that they had little effect on surface CD4 expression.
Results from immunoblot analysis (see Fig. 1 ample, all Nef alleles that effected CD4 down-regulation also directed detectable expression of Nef proteins in transiently transfected CEM T cells. The relatively weak CD4 downregulation by NA17 Nef and NB5 and NB9 alleles correlated with a relatively low steady-state-level expression of corresponding Nef proteins in CEM T cells. Only the NAll Nef was exceptional in that it had a potent effect on CI4 in spite of a relatively low steady-state expression. Thus, the relatively weak CD4 down-regulation may, in many cases, reflect decreased stability of the corresponding Nef proteins. In contrast, the weak NA4 allele is clearly exceptional because the steady-state-level expression of NA4 Nef was comparable to that of NL43 Nef protein.
Mutations in Conserved Nef Motifs Disrupt CD4 Downregulation. To characterize HIV-1 nef alleles further, the nucleotide sequence of 14 nef isolates from patient SK1 and of 3 nef isolates from patient SK4 was determined. The predicted amino acid sequences of respective Nef proteins from SK1 segregated into two closely related families (NA groups I and II), for which consensus sequences are shown in Fig. 3 . Within each of these two groups the amino acid variation between Nef proteins was <1% (0.9%o and 0.3% within group I and II proteins, respectively). In contrast, each of the group I Nef sequences differed from those of group II at nine diagnostic positions (4.4% divergence). A total of 19 amino acid substitutions was found among SK1 clones ( Fig. 3 and Table 1 ). The consensus amino acid sequence derived from SK4 nef isolates differed from that of SK1 at 35 positions (17% divergence). Seventeen amino acid differences were found between NB clones (8.3% divergence, see Fig. 3 and Table 1 ). Fig. 3 ).
To identify amino acid residues associated with loss ofCD4 down-regulation by NA4, NA17, and HxB3 Nefs, mutations specific to these partially defective genes were transferred onto the background of the highly active NA7 nef allele. In an additional experiment the conserved Gly-2 was replaced with alanine. This mutation disrupts the N-terminal myristoylation site conserved in Nef proteins of both human and simian viruses (1, 23) . The effect of these mutations on CD4 down-regulation was quantitated and correlated with the steady-state expression level of mutant Nef proteins in a dose-response experiment. construct effected a decrease in CD4 expression and doses of 5 pug and higher saturated the response. In contrast, three of the tested mutations reduced down-regulation of surface CD4 by NA7 Nef (Fig. 4) . First, mutation that disrupted the N-terminal myristoylation site in the NA7.1 Nef essentially abolished CD4 down-regulation at DNA doses below 5 ug, whereas higher doses of 15 and 50 Ag effected a modest decrease in CD4 expression on the cell surface. As shown in Fig. 4B , immunoblot analysis of cytoplasmic extracts prepared from cells transfected with 15 pg and 50 ug of the wild-type CD3 NA7 or the CD3 NA7.1 constructs revealed that the steady-state expression level of mutant NA7.1 Nef was higher than that of NA7 Nef for both these doses (compare lanes 1 and 2 with 7 and 8, respectively). Thus, disruption of the conserved N-terminal myristoylation signal in Nef reduced CD4 down-regulation to a large extent. The second mutation, Asp-36 -+ Gly (NA7. down-regulation by severalfold (Fig. 4A ) despite similar steady-state expression of both mutant NA7.3 and wild-type NA7 Nefproteins (Fig. 4B , compare lanes 9 and 10 with lanes 1 and 2, respectively). Therefore, the NA7. (NA1, -3, -5, -6, -7, -8, -10, -11, -13, -15, and -17) , and group II consists of 3 clones (NA4, -14, and -18 ). Amino acid variation within group I and group II clones is shown in 11 and 12 with 1-5, Fig. 4B) . However, the steady-state level of NA7.17 Nef in cells transfected with 50 ug of this DNA was comparable to that directed by 5 .0 pg of the wild-type CD3 NA7 construct (compare lane 11 and 3, Fig. 4B ), which had a subsaturating effect on CD4 down-regulation (Fig. 4A) . Therefore, the NA7.17 mutation has a 2-fold effect and affects both the stability and some function(s) ofNefprotein required for CD4 down-regulation. The remaining four unique amino acid substitutions found in HxB3 Nef had no effect on CD4 down-regulation when tested on NA7 background (data not shown).
Finally, we analyzed two amino acid changes found in the defective NA17 Nef allele ( (24) . Most amino acid replacements identified among Nef proteins from SK1 patients, except for those found in NA4 and NA17 Nef proteins, represented conservative amino acid substitutions. Thus, the observed divergence is likely to represent the preexisting heterogeneity of Nef in vivo in the SK1 patient rather than errors generated during PCR amplification in vitro. The two predominant families of NA Nef sequences observed are consistent with two major HIV-1 quasispecies that evolved in the SK1 patient but may reflect two independent infection events.
Evidence from experiments presented here strongly suggests that CD4 down-regulation reflects a conserved, selected in vivo function of nef. (i) Approximately 80%o of all nef alleles, including all those that directed detectable expression of Nef protein, down-regulated surface CD4 antigen upon transient expression in CEM T cells. The observation that the remaining 20% of SK1 nefalleles showed no effect on surface CD4 expression is not contradictory. A similar frequency of functionally defective alleles (30%) was observed before with the HIV-1 tat gene, which is essential for the viral life cycle (25) . (ii) Although sequence variation observed among primary isolates of Nef proteins and the NL43 Nef amounted altogether to >40 amino acid substitutions, most reflected conservative changes with little or no detectable effect on CD4 down-regulation. (iii) CD4 down-regulation was disrupted by nonconservative replacements in amino acid motifs that are conserved among human and simian Nef proteins. Specifically, an intact N-terminal myristoylation site, which is invariantly found in both HIV-1 and HIV-2/simian immunodeficiency virus Nef proteins, was required for full Nef activity. Moreover, CD4 down-regulation is also disrupted by a mutation altering the conserved cysteine found in all HIV-1 Nefs in the central domain that is highly conserved between human and simian Nef proteins (1) .
CD4 down-regulation by nef has been observed before in human and murine T cells stably expressing nef alleles derived from some (15, 18, 23) , but not the other HIV-1 isolates that have been repeatedly passaged in vitro (18 (17) .
It is well established that dynamics of disease progression can vary greatly among HIV-infected people. Results from in vivo experiments in rhesus monkeys indicated that nef is essential for simian immunodeficiency virus pathogenesis (3) and nef-deficient simian immunodeficiency virus can protect infected animals upon subsequent superinfection with the wild-type virus (26) . Methodology described here provides a quantitative assay to assess nef function in HIV-infected people and to establish whether alterations in nef are associated with differences in disease progression in human AIDS.
